Dex could not induce the loss of HLA-DR+ expression on healthy monocytes, but reduced CCL2 expression in a series of GBM cell lines and, furthermore, inversely correlated with serum CCL2 levels in a dose-dependent manner. Here, CCL2 is linked to glioblastoma.